Journals / Southern Clinics of Istanbul Eurasia / 2021 / Cilt: 32 - Sayı: 2

The Discriminative Power of Inflammatory Markers in Patients with Mild-To-Moderate Acute Pancreatitis: Mean Platelet Volume, Neutrophil-Lymphocyte Ratio, Lymphocyte-Monocyte Ratio, and Neutrophil-Monocyte Product

Pages
159–164
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During AP from onset to remission, the changes in MPV had no benefit but the change in WBC was significant regardless of AP severity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The exact parameters that differentiate mild acute pancreatitis (AP) from moderate AP are still unclear.
📊
Key Findings & Data:Results: A total of 217 AP patients were retrieved from the system, and the final study population consisted of 183 AP (84.3%).
💡
Conclusion & Impact:During AP from onset to remission, the changes in MPV had no benefit but the change in WBC was significant regardless of AP severity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The exact parameters that differentiate mild acute pancreatitis (AP) from moderate AP are still unclear. The primary aim of this study was to evaluate the prognostic utility of recently used inflammatory parameters in AP patients. Methods: We retrospectively collected the level of inflammatory parameters of patients who were diagnosed with AP at the onset and remission of the disease. The inflammatory parameters – mean platelet volume (MPV), neutrophil-lymphocyte ratio (NLR), neutrophil- monocyte product (NMP), and platelet-lymphocyte ratio (PLR) – were derived from the electronic patient database. The day of the presentation to the emergency department (ED) was accepted as the day of the symptom onset, and the day when the patient declared to be pain free and started to take oral nutrition was accepted as the date of remission. We also calculated the clinical utility metrics such as positive and negative likelihood ratios at this threshold. Results: A total of 217 AP patients were retrieved from the system, and the final study population consisted of 183 AP (84.3%). According to revised Atlanta classification, 142 (77.6%) patients were mild AP (MAP) and 41 (22.4%) were moderate and severe AP (MSAP-SAP). Median neutrophil and lymphocyte counts, PLR, NLR, and NMP were all significantly higher, and lymphocyte-monocyte ratio was significantly lower in MAP group. At remission, the median MPV level was significantly higher (p=0.0062), and median white blood cell (WBC) level was significantly lower (p<0.0001). The same trend was observed in MAP group for both MPV and WBC, but not present for MPV in MSAP-SAP group. Conclusion: We found that all inflammatory markers and ratios were significantly different between MAP and MSAP groups. Among those markers, NLR was the most powerful to discriminate between those groups. During AP from onset to remission, the changes in MPV had no benefit but the change in WBC was significant regardless of AP severity.

🔖

Cite This Article

AKOĞLU, E. Ü., ÖZDEMİR, S., AK, R., ÖZTÜRK, T. C. (2021). The Discriminative Power of Inflammatory Markers in Patients with Mild-To-Moderate Acute Pancreatitis: Mean Platelet Volume, Neutrophil-Lymphocyte Ratio, Lymphocyte-Monocyte Ratio, and Neutrophil-Monocyte Product. Southern Clinics of Istanbul Eurasia, Cilt: 32 - Sayı: 2, 159–164. https://ajindex.com/articles/397323

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Cruz-Santamaría DM, Taxonera C, Giner M. Update on pathogenesis and clinical management of acute pancreatitis. World J Gastrointest Pathophysiol 2012;3:60–70
  2. Yousaf M, McCallion K, Diamond T. Management of severe acute pancreatitis. Br J Surg 2003;90:407–20
  3. Karpavicius A, Dambrauskas Z, Sileikis A, Vitkus D, Strupas K. Value of adipokines in predicting the severity of acute pancreatitis: Comprehensive review. World J Gastroenterol 2012;18:6620–7
  4. Beduschi MG, Mello AL, Von-Mühlen B, Franzon O. The PANC 3 score predicting severity of acute pancreatitis. Arq Bras Cir Dig 2016;29:5–8
  5. Limon O, Sahin E, Kantar FU, Oray D, Ugurhan AA. A rare entity in ED: Normal lipase level in acute pancreatitis. Turk J Emerg Med 2016;16:32–4
  6. Matull WR, Pereira SP, O’Donohue JW. Biochemical markers of acute pancreatitis. J Clin Pathol 2006;59:340–4
  7. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69–81
  8. Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: A large population- based study. Gut 2008;57:1698–703
  9. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: Value of CT in establishing prognosis. Radiology 1990;174:331–6
  10. Beyazit Y, Sayilir A, Torun S, Suvak B, Yesil Y, Purnak T, et al. Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis. Clin Res Hepatol Gastroenterol 2012;36:162–8
  11. Chen L, Lu G, Zhou Q, Zhan Q. Evaluation of the BISAP score in predicting severity and prognoses of acute pancreatitis in Chinese patients. Int Surg 2013;98:6–12
  12. Jeon TJ, Park JY. Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis. World J Gastroenterol 2017;23:3883–9
  13. Han C, Zeng J, Lin R, Liu J, Qian W, Ding Z, et al. The utility of neutrophil to lymphocyte ratio and fluid sequestration as an early predictor of severe acute pancreatitis. Sci Rep 2017;7:10704
  14. Li Y, Zhao Y, Feng L, Guo R. Comparison of the prognostic values of inflammation markers in patients with acute pancreatitis: A retrospective cohort study. BMJ Open 2017;7:e013206
  15. Liu J, Bai Y, Aziguli A, Zhang YL. Value of neutrophil-monocyte product combined with serum creatinine in assessing the severity of acute pancreatitis. Nan Fang Yi Ke Da Xue Xue B